Archean Chemical Industries Ltd

AI
Archean Chemical Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Archean Chemical Industries Ltd

₹ 425 -0.98%
05 Nov - close price
archeanchemicals.com BSE: 543657 NSE: ACI
About

Archean Chemical Industries Limited is India's largest exporter of bromine and industrial salt in Fiscal 2021. The company is the leading specialty marine chemical manufacturer in India and is focused on producing and exporting bromine, industrial salt, and sulphate of potash to customers around the world.[1]

Key Points

Business Area[1]
The company is specialty marine chemicals company engaged in the production of Industrial Salt, Bromine and Sulphate of Potash (SOP) from natural sea brine resources. The company operates an integrated business model supported by strategic brine reserves and captive port infrastructure, while also expanding into bromine derivatives, specialty chemicals, energy storage and semiconductor materials to strengthen its long-term growth portfolio.

Website BSE NSE
  • Market Cap ₹ 5,247 Cr.
  • Current Price ₹ 425
  • High / Low ₹ 660 / 423
  • Stock P/E 52.6
  • Book Value ₹ 159
  • Dividend Yield 0.59 %
  • ROCE 7.41 %
  • ROE 5.42 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has been maintaining a healthy dividend payout of 21.1%
  • Company's working capital requirements have reduced from 49.5 days to 10.8 days

Cons

  • Company has a low return on equity of 11.0% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE Commodities Nifty Microcap 250 Nifty Total Market BSE 1000 Nifty Smallcap 500

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
290 413 284 213 240 242 346 292 233 255 301 327 297
195 267 197 141 166 162 257 214 171 200 257 260 227
Operating Profit 95 145 87 71 75 80 88 78 63 54 44 67 70
OPM % 33% 35% 31% 33% 31% 33% 26% 27% 27% 21% 15% 21% 24%
11 9 12 10 -29 9 8 8 6 7 5 6 4
Interest 2 2 2 2 3 3 0 5 6 4 10 5 5
Depreciation 18 18 18 19 19 20 21 23 24 24 23 23 24
Profit before tax 87 135 80 61 23 66 75 58 40 33 16 44 46
Tax % 24% 25% 28% 26% 31% 27% 28% 31% 27% 28% 23% 31% 32%
66 102 58 45 16 48 54 40 29 24 12 30 31
EPS in Rs 5.36 8.23 4.67 3.64 1.28 3.89 4.34 3.26 2.36 1.91 1.09 2.49 2.60
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
608 1,130 1,441 1,330 1,041 1,081 1,180
460 663 807 867 726 842 944
Operating Profit 148 467 634 463 315 239 236
OPM % 24% 41% 44% 35% 30% 22% 20%
9 12 43 43 -3 27 22
Interest 122 162 97 8 8 26 25
Depreciation 52 67 69 70 79 93 93
Profit before tax -17 251 512 427 224 147 139
Tax % 117% 25% 25% 25% 28% 28%
-36 188 383 319 162 105 98
EPS in Rs -3.76 19.54 31.09 25.85 13.14 8.66 8.09
Dividend Payout % 0% 0% 8% 12% 23% 29%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: -9%
TTM: 6%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -35%
TTM: -42%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -7%
1 Year: -35%
Return on Equity
10 Years: %
5 Years: 18%
3 Years: 11%
Last Year: 5%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Equity Capital 19 25 25 25 25 25
Reserves 243 1,406 1,677 1,839 1,910 1,939
897 69 98 235 466 551
372 255 255 290 264 313
Total Liabilities 1,531 1,755 2,055 2,389 2,665 2,827
1,086 1,110 1,160 1,378 1,383 1,499
CWIP 17 36 48 69 182 121
Investments 11 210 350 339 257 251
417 399 497 603 843 957
Total Assets 1,531 1,755 2,055 2,389 2,665 2,827

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
315 496 379 176 140
-110 -290 -307 -246 -293
-224 -212 -33 65 154
Net Cash Flow -19 -6 40 -5 1
Free Cash Flow 218 397 249 -81 -242
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 67% 82% 106% 73% 83%

Ratios

Consolidated / View Standalone

Mar 2020 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 49 30 43 58 43
Inventory Days 530 1,221
Days Payable 416 598
Cash Conversion Cycle 49 30 157 58 666
Working Capital Days 49 41 54 84 11
ROCE % 45% 25% 13% 7%

Insights

In beta
Mar 2020 Mar 2021 Mar 2022 Mar 2024 Mar 2025 Mar 2026
Bromine Sales Volume
MT ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Industrial Salt Sales Volume
MT ・Standalone data
Industrial Salt Installed Capacity
MTPA ・Standalone data
Total Customer Count
Count ・Standalone data
Bromine Installed Capacity
MTPA ・Standalone data
Acume (Bromine Derivatives) Capacity Utilization
%
Bromine Derivatives (Acume) Sales Volume
MT
SOP (Sulphate of Potash) Sales Volume
MT ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
53.46% 53.46% 53.46% 53.46% 53.44% 53.44% 53.44% 53.44% 53.43% 53.43% 53.43% 53.43%
4.15% 5.86% 9.53% 10.17% 10.65% 10.93% 11.05% 11.16% 11.08% 11.09% 11.00% 10.40%
28.69% 27.13% 21.04% 22.02% 22.86% 23.17% 24.69% 25.51% 25.26% 25.83% 24.18% 21.34%
0.00% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
13.71% 13.54% 15.96% 14.37% 13.06% 12.44% 10.84% 9.90% 10.24% 9.67% 11.40% 14.83%
No. of Shareholders 92,5711,06,78898,76295,99994,95885,85675,69770,85269,90064,92567,11370,389

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls